Valuation: EDAP TMS S.A.

Market Cap 203M 177M 164M 150M 285M 19.53B 290M 1.95B 767M 9.55B 762M 746M 32.9B P/E 2026 *
-6.24x
P/E 2027 * -8.43x
Enterprise Value 203M 177M 164M 150M 285M 19.53B 290M 1.95B 767M 9.55B 762M 746M 32.9B EV / Sales 2026 *
3.11x
EV / Sales 2027 * 2.72x
Free-Float
32.89%
Yield 2026 *
-
Yield 2027 * -
1 day+0.83%
1 week+0.65%
Current month+5.41%
1 month+14.95%
3 months+55.11%
6 months+33.50%
Current year+65.96%
1 week 5.3
Extreme 5.3
5.64
1 month 4.65
Extreme 4.65
5.64
Current year 3.1
Extreme 3.1
5.64
1 year 1.21
Extreme 1.21
5.64
3 years 1.21
Extreme 1.21
9.45
5 years 1.21
Extreme 1.21
12.65
10 years 1.21
Extreme 1.21
12.65
Manager TitleAgeSince
Chief Executive Officer 64 01/05/2023
Director of Finance/CFO 55 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 64 01/08/2023
Chairman 64 01/09/2024
Director/Board Member 62 08/07/2024
Date Insider Type Main position Quantity % Market Cap.
05-12Free

SVP, Marketing & Product Mgmt.

190,000 0.5145%
05-12Free

Chief Financial Officer

264,141 0.7153%
05-12Free

Chairman

114,285 0.3095%
Change 5-day change 1-year change 3-year change Capi.($)
+0.83%+0.65%+271.43%-37.39% 203M
+0.23%+4.93%+28.06%+1.91% 198B
+2.50%-6.29%-24.06%+9.93% 134B
+0.87%+5.25%+4.11%-15.55% 141B
+0.96%-3.95%-58.41%-18.19% 63.36B
-3.13%-6.80%+13.62%-5.81% 51.87B
+1.34%+1.46%-24.75%-32.52% 43.77B
-0.36%+4.37%+19.28%+13.92% 38.18B
-0.39%+1.84%+29.48%+38.95% 36.96B
+2.50%-2.29%-15.04%-22.16% 28.05B
Average +0.52%-2.05%+24.37%-6.69% 73.62B
Weighted average by Cap. +0.53%-2.03%+0.40%-2.73%

Financials

2026 *2027 *
Net sales 65.18M 56.99M 52.57M 48.33M 91.57M 6.27B 93.13M 628M 246M 3.07B 245M 239M 10.57B 74.6M 65.23M 60.17M 55.31M 105M 7.18B 107M 718M 282M 3.51B 280M 274M 12.09B
Net income -32.13M -28.09M -25.92M -23.82M -45.14M -3.09B -45.91M -309M -121M -1.51B -121M -118M -5.21B -25.95M -22.69M -20.93M -19.24M -36.45M -2.5B -37.08M -250M -98.04M -1.22B -97.45M -95.32M -4.21B
Net Debt - -
Logo EDAP TMS S.A.
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
Employees
289
Date Price Change Volume
16/07/26 $5.460 +0.83% 27,808
14/07/26 $5.415 -0.28% 121,369
13/07/26 $5.430 -0.09% 55,925
10/07/26 $5.435 -0.82% 46,561
09/07/26 $5.480 +1.01% 44,466
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
5.415USD
Average target price
6.875USD
Spread / Average Target
+26.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. FOCL Stock